EZH2 overexpression indicates a poor prognosis for patients with NSCLC, this effect appears also significant when the analysis is restricted in Asian population, lung AC and stage I patients, but not among Caucasians. The gene discussed is EZH2; the disease is non-small cell lung carcinoma.